ReviewAnnals of neurology2008
Rapidly progressive dementia.
Review in Annals of neurology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
141 citing papers in PubMed.
- Ring trial of 2nd generation RT-QuIC diagnostic tests for sporadic CJD.Annals of clinical and translational neurology · 2020Trial
- Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.Brain : a journal of neurology · 2015Trial
- Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).PLoS pathogens · 2012Trial
- Probable Sporadic Creutzfeldt-Jakob Disease Presenting as Rapidly Progressive Dementia: A Case Report From Georgia.Cureus · 2026Article
- Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.Neurology · 2026Observational
- Article
- Standardizing "Rapid": Applying the Clinical Dementia Rating to Define Rapidly Progressive Dementia.Neurology · 2026Article
- Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease.Brain : a journal of neurology · 2026Article
- A single large-scale mitochondrial DNA deletion presenting as rapidly progressive dementia in a 35-year-old male.NPJ dementia · 2026Article
- Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.Annals of neurology · 2025Article
- Structural exposure of different microtubule binding domains determines the propagation and toxicity of pathogenic tau conformers in Alzheimer's disease.PLoS pathogens · 2025Article
- The Creutz of a veteran's life: an emergency department presentation of rapidly progressive dementia and myoclonus-a case report.AME case reports · 2025Article
- Lymphomatosis cerebri caused by adult T cell leukemia/lymphoma: a differential diagnosis for depression: a case report.Journal of medical case reports · 2024Article
- Improving Early Recognition of Treatment-Responsive Causes of Rapidly Progressive Dementia: The STAMAnnals of neurology · 2024Observational
- Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia.Annals of neurology · 2024Article
- Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- MRI abnormalities in Creutzfeldt-Jakob disease and other rapidly progressive dementia.Journal of neurology · 2024Article
- Crucial differential diagnosis of rapidly progressive dementia: A case of leptomeningeal metastasis.PCN reports : psychiatry and clinical neurosciences · 2023Article
- Caregiver Experiences Navigating the Diagnostic Journey in a Rapidly Progressing Dementia.Journal of geriatric psychiatry and neurology · 2023Article
- Prevalence and outcomes of rapidly progressive dementia: a retrospective cohort study in a neurologic unit in China.BMC geriatrics · 2023Article
81 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In contrast with more common dementing conditions that typically develop over years, rapidly progressive dementias can develop subacutely over months, weeks, or even days and be quickly fatal. Because many rapidly progressive dementias are treatable, it is paramount to evaluate and diagnose these patients quickly. This review summarizes recent advances in the understanding of the major categories of RPD and outlines efficient approaches to the diagnosis of the various neurodegenerative, toxic-metabolic, infectious, autoimmune, neoplastic, and other conditions that may progress rapidly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.